l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with ketanserin in 3 studies
Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
---|---|---|---|---|---|
138 | 7 | 2 | 3,094 | 335 | 283 |
Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | ketanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarke, KA; Parker, AJ; Stirk, GC | 1 |
Taché, Y; Yoneda, M | 2 |
3 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and ketanserin
Article | Year |
---|---|
Potentiation of motoneurone excitability by combined administration of 5-HT agonist and TRH analogue.
Topics: Animals; Anterior Horn Cells; Drug Synergism; Female; Fenclonine; Ketanserin; Methoxydimethyltryptamines; Methysergide; Motor Neurons; Piperidines; Pyrrolidonecarboxylic Acid; Rats; Serotonin; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1985 |
Serotonin enhances gastric acid response to TRH analogue in dorsal vagal complex through 5-HT2 receptors in rats.
Topics: Animals; Drug Synergism; Gastric Acid; Globus Pallidus; Ketanserin; Male; Medulla Oblongata; Microinjections; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thyrotropin-Releasing Hormone; Vagus Nerve | 1995 |
Potentiating interactions between medullary serotonin and thyrotropin-releasing hormone-induced gastric erosions in rats.
Topics: Animals; Cold Temperature; Indomethacin; Injections; Injections, Intravenous; Ketanserin; Male; Medulla Oblongata; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Restraint, Physical; Serotonin; Stomach Ulcer; Stress, Psychological; Thyrotropin-Releasing Hormone | 1993 |